Vectors, primers, and recombinant proteins used in this study are listed in SI Appendix, Tables S2-4, respectively. In vitro experiments presented in this study were carried out using protein expressed from a pET-28a-shkA plasmid. The pET-28a-shkA vector carrying the gene coding for full-length, wild-type ShkA (Uniprot: Q9ABT2) was the same as used in the preceding study (1). ShkA single-and multi-domain constructs, as well as point mutants (SI Appendix, Table S4 ) were generated from the pET-28a-shkA vector following the Q5 Site-Directed Mutagenesis Kit protocol (E0554, New England Biolabs) or following a standard Phusion polymerase-based (Thermo Fisher Scientific) cloning technique using the primers given in SI Appendix, Table S3 . The results verified by sequencing. The E. coli DH5α strain (Invitrogen) was used for cloning purposes. Bacteria were allowed to grow in lysogeny broth (LB; 10 g tryptone, 5 g yeast extract, 10 g NaCl) supplemented with 50 μg/ml Kanamycin (LB-Kan) and LB-Kan-containing agar plates at 37 °C. After successful cloning, plasmids were extracted from E. coli DH5α cells following QIAprep Spin Miniprep Kit protocol (QIAGEN) and used to transform the expression strains E. coli BL21(DE3) or similarly efficient Rosetta cells (Novagen). For protein expression, adequate amounts of LB-Kan media were inoculated with 1% pre-culture of transformed cells. Grown cultures were induced with 1 mM isopropyl 1-thio-β-Dgalactopyranoside (IPTG) at an OD600 of 0.6 -0.8. The incubation temperature was reduced to 22 °C for overnight protein expression. Cells were harvested by centrifugation at 9'000 RCF for 10 minutes at 4 °C.
40 % v/v ethylene glycol and 20 % w/v PEG 8000 (Morpheus-H7, Molecular Dimensions) at room temperature. Surprisingly, the resulting structure did not contain c-di-GMP. Probably, the major fraction of molecules that had c-di-GMP bound and, thus, an open, mobile domain arrangement (see main text) did not crystallise, but rather the minor fraction of uncomplexed (c-di-GMP) molecules with their compact, locked domain arrangement. Crystals of ShkARec1 were obtained in the presence of c-di-GMP (1:3 molar ratio) at a concentration of 20 mg/ml in 0.2 M Ammonium sulfate, 0.1 M Bis-Tris pH 6.5 and 25% w/v PEG 3350 (SG01-F5, Molecular Dimensions) at 4 °C in cold room.
Data collection and structure determination X-ray diffraction data were collected at the Swiss Light Source (SLS), Villigen, Switzerland, at 100 K. Data were indexed, integrated, scaled, and merged using XDS (2) and the CCP4i2 suite (3) . The crystal structure of full-length ShkA was solved by molecular replacement (4) , using a homology model of ShkA (CA) based on the CA structure of DivL (PDB code 4q20) as a first search model. After having placed the CA domain successfully, subsequent molecular replacement searches were conducted using a Chainsaw/CCP4 (3, 5) model of Rec1 derived from the first Rec domain of 3luf with helix 3 removed. The Rec2 domain was localised with help of a Chainsaw model derived from the second receiver domain of the same PDB entry. At this time point, clear density was obtained for the DHp bundle and its model was obtained by molecular replacement with the individual α1 and α2 DHp helices of DivL (4q20). The ShkARec1 crystal structure was also solved by molecular replacement (6) using the corresponding domain of the full-length ShkA structure.
For both crystal structures, phases and models were further improved by automated model building using PHENIX AutoBuild (7) . Extensive additional manual model building was carried for the Rec1 -Rec2 linker containing DDR motif and the loop (connector) between DHp α1 and α2 in Coot (8) . Iterative rounds of model building and refinement in Refmac5 (3) resulted in a map of sufficient quality to place the missing parts of the peptide chain along with the ligands. Figures were prepared with Dino (http://dino3d.org).
Nuclear Magnetic Resonance
All NMR spectra were recorded at 20 °C on a Bruker Avance-700 MHz spectrometer equipped with a cryogenically cooled triple-resonance probe. The following experiments were recorded with the ShkARec1 and the peak intensities were fitted to an equation of the form: Peak Intensity = A exp(-T/T2). The error for T2 was derived from the fit of the data by bootstrapping for the isolated domains and as the standard deviation for two independent measurements for full-length ShkA.
Isothermal Titration Calorimetry (ITC)
Measurements were performed with a MicroCal VP-ITC calorimeter (Malvern Instruments) at 25 °C. Samples were diluted in ITC buffer (100 mM NaCl, 20 mM Tris-HCl, 5 mM MgCl2, 1 mM DTT, pH 7.5). A total of 30 injections of 10 μl each (besides the first injection with 2 μl) were made with a spacing time of about 400 seconds. Thermograms were analysed with AFFINImeter (11) (S4SD, Santiago de Compostela, Spain) using a 1:1 binding model with the stoichiometry fixed to 1. Tested ligands: AMP-PNP (Sigma Aldrich), ADP (Sigma Aldrich), c-di-GMP (Biolog, Bremen, Germany).
Fluorometric binding competition assay
The dissociation constant of 2'-Fluo-AHC-c-di-GMP (fluo-c-di-GMP; Biolog, Bremen, Germany) to full-length ShkA and its variant was determined by monitoring the change in fluorescence intensity upon protein titration. This was followed by c-di-GMP titration to protein in presence of fluo-c-di-GMP to compete out the labelled ligand. Data were fitted to the competitive ligand binding model given by Z-H. Wang (12) to obtain the dissociation constant of unlabelled c-di-GMP. Experiments were performed with BioTek Synergy H1 and 2 plate readers. Fluorescence intensity was recorded at either λem = 517 nm with λex = 494 nm (Synergy 
Sedimentation velocity analytical ultracentrifugation (SV-AUC)
Sedimentation velocity was measured with a Beckman Coulter XL-I ultracentrifuge with interference optics.
Experiments were performed with 12 mm double-sector centerpieces, 8-hole rotors (Beckman An50Ti) at 42 krpm and 25 °C. Samples (1 mg/ml = 18 μM) were prepared in SEC buffer. Viscosity (0.901 cp) and density (1.0035 g/ml) of the buffer were measured separately at 25 °C with an Anton-Paar instrument. Analysis of the raw data was performed using SEDFIT (13) . The "Continuous c(S) distribution with bimodal f/f0" fitting model was used to mitigate the effect of small molecules/contaminants present in the samples.
β-Gal assay
Plasmids for β-Gal assays were constructed as follows. A fragment encoding the N-terminal predicted unstructured part of RPA4224, a predicted ortholog of the anti-sigma factor NepR (14) , was PCR-amplified from Rhodopseudomonas palustris CG009 genomic DNA with primers 17/18 (pQF-shkA-liDDR) or 19/20 (pQF-shkA-DDRli), see SI Appendix, Table S3 , digested respectively with PstI or MluI (New England Biolabs) and cloned in pQF-shkA predigested with either restriction enzyme. The correct orientation of the inserted fragment was verified by sequencing. Plasmids pQF-shkA and pQF-shkA(D369N), and the parental plasmid pQF, were described previously (1, 15) . Strains (AKS297 or UJ9691) harboring the pAK502-spmX reporter plasmid (1) were transformed with pQF-shkA, pQF-shkA(D369N), pQF-shkA-liDDR or pQF-shkA-DDRli by electroporation. Single colonies were inoculated in 2 ml PYE supplemented with chloramphenicol (1 µg/ml) and oxytetracyline (1 µg/ml) and grown overnight at 30°C in a drum roller. Cultures were diluted the next day 20-fold in 2 ml of the same medium, followed by further incubation for an additional 4.5 h under the same conditions before sampling. β-Gal assays were essentially performed as described before according to the method of Miller (16) .
Protein phosphorylation assay
Net-phosphorylation of full-length ShkA and its variants were analysed by auto-radiography as described in ref. (17) . In short, reactions were run in enzymatic reaction buffer (30 mM Tris-HCl, pH 7.5, 50 mM NaCl, 50 Wet gels were exposed to phosphor screen (0.5-3 hrs) before being scanned using a Typhoon FLA 7000 imaging system (GE Healthcare). Background subtracted autoradiograph band intensities were determined with ImageStudio (Li-COR, Lincoln, Nebraska USA).
Online ion exchange chromatography (oIEC) assay for acquisition of nucleotide turn-over progress curves
Nucleotide concentrations of an ongoing enzymatic reaction were determined in real-time by fast protein liquid chromatography (FPLC) using an ÄKTA Purifier instrument (GE Healthcare) equipped with a 1 mL Resource Q anion exchange (AEX) column and an A-905 autosampler. With the newly developed oIEC method we acquired automatically quantitative enzyme progress curves by repetitive cycles of sample loading followed by salt gradient elution. Thereby, the reaction was started by addition of ATP substrate to the reaction mix in reaction buffer at t=0. This was followed by sequential aspiration of aliquots to the column in loading buffer (20 mM Tris-HCl, pH 8.0) at defined time points. Note that when the sample arrives on the column the reaction is stopped without the need of further intervention due to substrate immobilization.
Elution was achieved by a linear gradient from 0 -1 M (NH4)2SO4. The absorbance at 260 nm was constantly monitored using a UV-900 monitor (GE Healthcare). The chromatogram peaks corresponding to the nucleotides were fitted by Gaussians using a custom made automized routine implemented in ProFit 7 (QuantumSoft, Uetikon am See, Switzerland). Peak areas (mAU • ml) were converted to molar nucleotide amounts using a scale factor obtained by calibration with a set of serially diluted ATP samples.
Thermodynamic modelling of reversible autophosphorylation
The equilibrium constant K of reversible protein (E) auto-phosphorylation (inset to Fig. 4B ) is given by
To solve the reaction for given total enzyme (Etot) and ATP (ATPtot) concentrations, we consider the following (non-equilibrium) starting concentrations
which will reach at equilibrium
which can be solved analytically (WolframAlpha, http://www.wolframalpha.com) for x. Substituting x into equations 4 yields the four equilibrium concentrations.
In case of a dimeric enzyme with two phosphorylation sites, four reactions have to be considered 
Thermodynamic modelling, ligand induced change in equilibrium (LCCE)
For an enzyme (total concentration Etot) in dynamic equilibrium between two states (active/open Eo, inactive/closed Ec) and with a ligand L that binds exclusively to the active Eo-state (inset to Fig. 4B ), the following equations can be formulated
(3)
Under saturating conditions and assuming that ligand binding does not interfere with activity, the activity of the enzyme is proportional to the fraction of active enzymes
For large ligand concentrations (Ltot>>Kd and Ltot>>Etot) we can set L=Ltot and the term (10) can be neglected,
which has the form of a hyperbolic activation curve with an activation constant Kact of
In absence of ligand, the term (11) can be neglected and (10) will give
which is the residual fraction of active enzymes.
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